Partner Headlines - BCRX

  1. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga
  2. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst ...

    Benzinga
  3. Benzinga's Top Initiations

    Benzinga
  4. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, ...

    Benzinga
  5. Benzinga's Top #PreMarket Gainers

    Benzinga
  6. Benzinga's Top Downgrades

    Benzinga
  7. Benzinga's Top Initiations

    Benzinga
  8. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under ...

    Benzinga
  9. US Stock Futures Gain Ahead Of GDP Data

    Benzinga
  10. BioCryst Files Peramivir NDA for Influenza

    Benzinga
  11. Benzinga's Top #PreMarket Gainers

    Benzinga
  12. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary ...

    Benzinga
  13. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients ...

    Benzinga
  14. Benzinga's Top Pre-Market Gainers

    Benzinga
  15. BioCryst Awarded Up to $22M Contract by the NIAID to Develop ...

    Benzinga
  16. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' ...

    Benzinga
  17. UPDATE: JMP Securities Raises PT on BioCryst Pharmaceuticals ...

    Benzinga
  18. Benzinga's Top Pre-Market Gainers

    Benzinga
  19. FDA Removes Clinical Hold on BioCryst's BCX 4161 -8K

    Benzinga
  20. Benzinga's Top Pre-Market Gainers

    Benzinga
  21. BioCryst Prices 4M Share Offering at $4.40/Share

    Benzinga
  22. UPDATE: Bank of America Downgrades BioCryst Pharmaceuticals on ...

    Benzinga
  23. Benzinga's Top Pre-Market Losers

    Benzinga
  24. UPDATE: Bank of America Resumes Coverage on BioCryst Pharmaceuticals ...

    Benzinga
  25. Benzinga's Small Cap Movers for Wednesday January 2, 2013

    Benzinga
  26. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  27. BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate ...

    Benzinga
  28. BioCryst Broad-Spectrum Antiviral BCX4430 Shows Effective and ...

    Benzinga
  29. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  30. BioCryst Announces Withdrawal of BCX5191 Investigational New ...

    Benzinga
  31. Benzinga's M&A Chatter for Thursday October 18, 2012

    Benzinga
  32. BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

    Benzinga
  33. BioCryst Pharmaceuticals, Presidio Pharmaceuticals to Merge

    Benzinga
  34. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  35. A Peek Into The Market Before The Trading Starts

    Benzinga
  36. IHS, Ebix Included in Stocks Up on High Volume Friday

    FoxBusiness
  37. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  38. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  39. Swine Flu Outbreak in Mexico Sends Small BioPharma Sky-High

    Benzinga
  40. Benzinga's Microcap Movers for Thursday January 12, 2012

    Benzinga
  41. Oink Oink: Profit From The Return Of Swine Flu

    Benzinga
  42. UPDATE: Bank of America Meets with BioCryst Pharma Management ...

    Benzinga
  43. Bank of America Comments on BCRX Phase-3 Data

    Benzinga
  44. BoardCentral StockTalk - weekly update: AAPL, F, MSFT, KERX, ...

    BoardCentral
Trading Center